文献速递心律失常冠心病瓣膜病与结构性心脏病

心脏电生理与介入手术患者的抗栓治疗:JACC前沿综述

Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures: JACC State-of-the-Art Review.
PubMed 文献 · J Am Coll Cardiol · 2024-01-01

该综述针对接受心脏电生理与介入手术的患者,总结抗栓治疗在降低卒中/血栓栓塞风险与增加出血风险之间的平衡策略。文中指出多种指南与共识造成临床决策模糊,旨在提供基于证据的实用总结以指导临床医生和手术操作者。

要点

  • 抗栓治疗可降低卒中或血栓栓塞事件风险,但增加出血风险。
  • 老年患者合用口服抗凝药与抗血小板药会进一步增加出血风险。
  • 需根据每例患者情况谨慎选择抗栓治疗的时机、剂量与组合。

核心结论

  • 抗栓治疗在心脏电生理与介入手术患者中需权衡卒中/血栓栓塞预防与出血风险,应个体化选择时机、剂量与组合。

研究设计与样本

  • 本文为JACC前沿综述,旨在汇总不同心脏电生理与介入手术中抗栓方法的循证实践摘要。

主要发现

  • 口服抗凝药与抗血小板治疗联用会进一步增加出血风险,尤其在老年接受心脏手术的人群中。
  • 已发表的多种指南与共识文件使该领域的临床决策场景更加模糊。

临床怎么用

  • 临床医生和心脏介入操作者应依据本综述提供的循证实践摘要,个体化选择抗栓治疗的时机、剂量与组合。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Electrophysiological and interventional procedures have been increasingly used to reduce morbidity and mortality in patients experiencing cardiovascular diseases. Although antithrombotic therapies are critical to reduce the risk of stroke or other thromboembolic events, they can nonetheless increase the bleeding hazard. This is even more true in an aging population undergoing cardiac procedures in which the combination of oral anticoagulants and antiplatelet therapies would further increase the hemorrhagic risk. Hence, the timing, dose, and combination of antithrombotic therapies should be carefully chosen in each case. However, the maze of society guidelines and consensus documents published so far have progressively led to a hazier scenario in this setting. Aim of this review is to provide-in a single document-a quick, evidenced-based practical summary of the antithrombotic approaches used in different cardiac electrophysiology and interventional procedures to guide the busy clinician and the cardiac proceduralist in their everyday practice.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Di Biase L, Lakkireddy DJ, Marazzato J, et al. Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024. PMID: 38171713. doi:10.1016/j.jacc.2023.09.831

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。